The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' It's only natural to consider a company's balance sheet when you examine how risky it is, since debt is often involved when a business collapses. We can see that Marumae Co., Ltd. (TSE:6264) does use debt in its business. But is this debt a concern to shareholders?
Why Does Debt Bring Risk?
Generally speaking, debt only becomes a real problem when a company can't easily pay it off, either by raising capital or with its own cash flow. If things get really bad, the lenders can take control of the business. However, a more frequent (but still costly) occurrence is where a company must issue shares at bargain-basement prices, permanently diluting shareholders, just to shore up its balance sheet. Of course, the upside of debt is that it often represents cheap capital, especially when it replaces dilution in a company with the ability to reinvest at high rates of return. When we think about a company's use of debt, we first look at cash and debt together.
What Is Marumae's Net Debt?
You can click the graphic below for the historical numbers, but it shows that as of February 2025 Marumae had JP¥4.35b of debt, an increase on JP¥3.19b, over one year. On the flip side, it has JP¥3.71b in cash leading to net debt of about JP¥632.0m.
How Healthy Is Marumae's Balance Sheet?
We can see from the most recent balance sheet that Marumae had liabilities of JP¥1.79b falling due within a year, and liabilities of JP¥3.76b due beyond that. Offsetting these obligations, it had cash of JP¥3.71b as well as receivables valued at JP¥2.36b due within 12 months. So it can boast JP¥518.0m more liquid assets than total liabilities.
This surplus suggests that Marumae has a conservative balance sheet, and could probably eliminate its debt without much difficulty.
Check out our latest analysis for Marumae
We measure a company's debt load relative to its earnings power by looking at its net debt divided by its earnings before interest, tax, depreciation, and amortization (EBITDA) and by calculating how easily its earnings before interest and tax (EBIT) cover its interest expense (interest cover). This way, we consider both the absolute quantum of the debt, as well as the interest rates paid on it.
Marumae has a low net debt to EBITDA ratio of only 0.31. And its EBIT covers its interest expense a whopping 49.5 times over. So you could argue it is no more threatened by its debt than an elephant is by a mouse. It was also good to see that despite losing money on the EBIT line last year, Marumae turned things around in the last 12 months, delivering and EBIT of JP¥1.1b. When analysing debt levels, the balance sheet is the obvious place to start. But you can't view debt in total isolation; since Marumae will need earnings to service that debt. So when considering debt, it's definitely worth looking at the earnings trend. Click here for an interactive snapshot.
Finally, a business needs free cash flow to pay off debt; accounting profits just don't cut it. So it's worth checking how much of the earnings before interest and tax (EBIT) is backed by free cash flow. Considering the last year, Marumae actually recorded a cash outflow, overall. Debt is usually more expensive, and almost always more risky in the hands of a company with negative free cash flow. Shareholders ought to hope for an improvement.

Our View
Marumae's interest cover was a real positive on this analysis, as was its net debt to EBITDA. In contrast, our confidence was undermined by its apparent struggle to convert EBIT to free cash flow. Considering this range of data points, we think Marumae is in a good position to manage its debt levels. Having said that, the load is sufficiently heavy that we would recommend any shareholders keep a close eye on it. There's no doubt that we learn most about debt from the balance sheet. However, not all investment risk resides within the balance sheet - far from it. To that end, you should learn about the 3 warning signs we've spotted with Marumae (including 2 which are significant) .
If, after all that, you're more interested in a fast growing company with a rock-solid balance sheet, then check out our list of net cash growth stocks without delay.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About TSE:6264
Marumae
Designs, manufactures, processes, and assembles precision machinery.
Proven track record with mediocre balance sheet.
Market Insights
Weekly Picks

Is this the AI replacing marketing professionals?
Pro Medicus: The Market Is Confusing a Lumpy Quarter With a Broken Business
The Rising Deal Risk That Helped Sink Netflix’s $72 Billion Bid for Warner Bros. Discovery
The Infrastructure AI Cannot Be Built Without
Recently Updated Narratives

Kratos Defense & Security Solutions (KTOS): Scaling "Attritable" Dominance in a New Era of Aerial Conflict.

BWX Technologies (BWXT): Powering the Nuclear Renaissance from Naval Depths to Medical Frontiers.

Merck & Co. (MRK): Scaling the "Post-Keytruda Hill" Through Diversified Blockbusters.
Popular Narratives
Nu holdings will continue to disrupt the South American banking market

Analyst Commentary Highlights Microsoft AI Momentum and Upward Valuation Amid Growth and Competitive Risks
